Improving effect of Curcumin on Chemoradiotherapy-Induced Enteritis of colorectal cancer: a randomized, double-blinded, placebo-controlled study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220429054699N1

Enrollment

Registered

2023-10-19

Start date

2017-04-05

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

RECTAL CANCER. Malignant neoplasm of rectum

Interventions

Intervention 1: Intervention group: Curcumin is a medicine to reduce inflammation. In this study, we intended to measure its effect on enterocolitis caused by radiation therapy. Therefore, from the fi

Eligibility

Sex/Gender

Male

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Rectal cancer Indication of chemo-Radiation

Exclusion criteria

Exclusion criteria: Hypersensitivity to traumatic

Design outcomes

Primary

Measure	Time frame
Chemo radiation side effect. Timepoint: weekly. Method of measurement: Visiting and filling out the Criteria for Adverse Events of intestinal form.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Ebrahimi

Esfahan University of Medical Sciences

aalliiee50@yahoo.com+98 913 308 0828

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026